Literature DB >> 22138896

New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.

Bruno Demoro1, Cynthia Sarniguet, Roberto Sánchez-Delgado, Miriam Rossi, Daniel Liebowitz, Francesco Caruso, Claudio Olea-Azar, Virtudes Moreno, Andrea Medeiros, Marcelo A Comini, Lucía Otero, Dinorah Gambino.   

Abstract

In the search for new therapeutic tools against neglected diseases produced by trypanosomatid parasites, and particularly against African Trypanosomiasis, whose etiological agent is n class="Species">Trypanosoma brucei, organoruthenium compounds with bioactive nitrofuran containing thiosemicarbazones (L) as co-ligands were obtained. Four ruthenium(II) complexes with the formula [Ru(2)(p-cymene)(2)(L)(2)]X(2), where X = Cl or PF(6), were synthesized and the crystal structures of two of them were solved by X-ray diffraction methods. Two of the complexes show significant in vitro growth inhibition activity against Trypanosoma brucei brucei and are highly selective towards trypanosomal cells with respect to mammalian cells (J774 murine macrophages). These promising results make the title organoruthenium compounds good lead candidates for further developments towards potential antitrypanosomal organometallic drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138896      PMCID: PMC3299570          DOI: 10.1039/c1dt11519g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  34 in total

Review 1.  Chemotherapy of trypanosomiases and leishmaniasis.

Authors:  Simon L Croft; Michael P Barrett; Julio A Urbina
Journal:  Trends Parasitol       Date:  2005-09-08

2.  Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.

Authors:  Lucía Otero; Marisol Vieites; Lucía Boiani; Ana Denicola; Carolina Rigol; Lucía Opazo; Claudio Olea-Azar; Juan Diego Maya; Antonio Morello; R Luise Krauth-Siegel; Oscar E Piro; Eduardo Castellano; Mercedes González; Dinorah Gambino; Hugo Cerecetto
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 3.  Metal-based antitumour drugs in the post genomic era.

Authors:  Paul J Dyson; Gianni Sava
Journal:  Dalton Trans       Date:  2006-03-28       Impact factor: 4.390

4.  Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.

Authors:  Carolina Urquiola; Marisol Vieites; Gabriela Aguirre; Adoración Marín; Beatriz Solano; Gabriel Arrambide; Pabla Noblía; María Laura Lavaggi; María H Torre; Mercedes González; Antonio Monge; Dinorah Gambino; Hugo Cerecetto
Journal:  Bioorg Med Chem       Date:  2006-05-18       Impact factor: 3.641

Review 5.  Approaches for the development of new anti-Trypanosoma cruzi agents.

Authors:  Diogo Rodrigo Magalhães Moreira; Ana Cristina Lima Leite; Ricardo Ribeiro dos Santos; Milena B P Soares
Journal:  Curr Drug Targets       Date:  2009-03       Impact factor: 3.465

6.  A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent.

Authors:  Julio Benítez; Lucía Guggeri; Isabel Tomaz; João Costa Pessoa; Virtudes Moreno; Julia Lorenzo; Francesc X Avilés; Beatriz Garat; Dinorah Gambino
Journal:  J Inorg Biochem       Date:  2009-07-24       Impact factor: 4.155

7.  Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.

Authors:  Julio Benítez; Lucía Guggeri; Isabel Tomaz; Gabriel Arrambide; Maribel Navarro; João Costa Pessoa; Beatriz Garat; Dinorah Gambino
Journal:  J Inorg Biochem       Date:  2008-11-07       Impact factor: 4.155

Review 8.  Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.

Authors:  Roberto A Sánchez-Delgado; Atilio Anzellotti
Journal:  Mini Rev Med Chem       Date:  2004-01       Impact factor: 3.862

9.  Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.

Authors:  Marisol Vieites; Pablo Smircich; Lucía Guggeri; Edgar Marchán; Alicia Gómez-Barrio; Maribel Navarro; Beatriz Garat; Dinorah Gambino
Journal:  J Inorg Biochem       Date:  2009-03-17       Impact factor: 4.155

Review 10.  Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.

Authors:  Daniel Dive; Christophe Biot
Journal:  ChemMedChem       Date:  2008-03       Impact factor: 3.466

View more
  7 in total

1.  Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells.

Authors:  Eva Iniguez; Antonio Sánchez; Miguel A Vasquez; Alberto Martínez; Joanna Olivas; Aaron Sattler; Roberto A Sánchez-Delgado; Rosa A Maldonado
Journal:  J Biol Inorg Chem       Date:  2013-07-24       Impact factor: 3.358

2.  Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.

Authors:  Alberto Martínez; Teresia Carreon; Eva Iniguez; Atilio Anzellotti; Antonio Sánchez; Marina Tyan; Aaron Sattler; Linda Herrera; Rosa A Maldonado; Roberto A Sánchez-Delgado
Journal:  J Med Chem       Date:  2012-04-09       Impact factor: 7.446

3.  Autophagic elimination of Trypanosoma cruzi in the presence of metals.

Authors:  Laís Pessanha de Carvalho; Edésio José Tenório de Melo
Journal:  J Microbiol       Date:  2019-08-28       Impact factor: 3.422

4.  An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release.

Authors:  G Kalaiarasi; S Rex Jeya Rajkumar; S Dharani; J G Małecki; R Prabhakaran
Journal:  RSC Adv       Date:  2018-01-04       Impact factor: 4.036

5.  Diglycosyl diselenides alter redox homeostasis and glucose consumption of infective African trypanosomes.

Authors:  Jaime Franco; Florencia Sardi; László Szilágyi; Katalin E Kövér; Krisztina Fehér; Marcelo A Comini
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-08-12       Impact factor: 4.077

6.  Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity.

Authors:  Oksana Desiatkina; Emilia Păunescu; Martin Mösching; Nicoleta Anghel; Ghalia Boubaker; Yosra Amdouni; Andrew Hemphill; Julien Furrer
Journal:  Chembiochem       Date:  2020-06-16       Impact factor: 3.164

7.  Iboga Inspired N-Indolylethyl-Substituted Isoquinuclidines as a Bioactive Scaffold: Chemoenzymatic Synthesis and Characterization as GDNF Releasers and Antitrypanosoma Agents.

Authors:  Mariana Pazos; Estefania Dibello; Juan Manuel Mesa; Dalibor Sames; Marcelo Alberto Comini; Gustavo Seoane; Ignacio Carrera
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.